Scleroderma
Armando Gabrielli, Enrico Vittorio Avvedimento, Thomas M. Krieg · New England Journal of Medicine · 2009
This account of the mechanisms of scleroderma highlights the genetic and molecular changes that cause the vascular changes and fibrosis in the disease. The role of autoantibodies, of which there are several in scleroderma, is unclear. The authors outline a stepwise process that begins with inflammation, reaches its zenith in fibrosis, and ends in atrophy.
Cited by 1,384 works. doi:10.1056/nejmra0806188
Authors
References
- Cancer-related inflammation
- Integrins
- Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.
- TGF‐β signaling and the fibrotic response
- Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLAST
- Reversible Oxidation and Inactivation of Protein Tyrosine Phosphatases In Vivo
- Novel gp91 phox Homologues in Vascular Smooth Muscle Cells
- Pericytes in the microvasculature
- Modulation of fibroblast proliferation by oxygen free radicals
- Systemic Sclerosis